These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3549246)

  • 1. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
    Hoyt EG; Hagberg RC; Billingham ME; Baldwin JC; Jamieson SW
    J Heart Transplant; 1988; 7(2):111-7. PubMed ID: 3284981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electron microscopic observation of the nephrotoxicity in rats receiving cyclosporine].
    Kimura S; Hasegawa S; Nakazono M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):563-71. PubMed ID: 3669468
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces cyclosporine nephrotoxicity in the rat.
    Thomson AW; McAuley FT; Whiting PH; Simpson JG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1242-3. PubMed ID: 2856270
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrotoxicity of cyclosporine G and A in the Sprague-Dawley rat.
    Duncan JI; Simpson JG; Thomson AW; Whiting PH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1391-2. PubMed ID: 3274338
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitochondrial alterations after cyclosporine and ischemia: insights on the pathophysiology of nephrotoxicity.
    Khauli RB; Strzelecki T; Kumar S; Fink M; Stoff J; Menon M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1395-7. PubMed ID: 3274339
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on nephrotoxicity of cyclosporine in human renal allograft and rat.
    Morozumi K; Shinmura I; Gotoh I; Yoshida A; Fujinami T; Uchida K; Yamada N; Tominaga Y; Nakanishi Y; Kanoh T
    Dev Toxicol Environ Sci; 1986; 14():153-6. PubMed ID: 3549247
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of long-term rat cardiac allograft survival in rats with multiple donor specific transfusions and cyclosporine.
    Perez RV; Heyd TJ; Munda R; Babcock G; Alexander JW
    Curr Surg; 1988; 45(1):9-12. PubMed ID: 3278865
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal toxicity of cyclosporin A in the rat.
    Thiel G; Torhorst J; Brunner FP
    Proc Clin Dial Transplant Forum; 1980; 10():62-6. PubMed ID: 7050995
    [No Abstract]   [Full Text] [Related]  

  • 10. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1403-6. PubMed ID: 3824502
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.
    Ijzermans JN; Singh SK; de Bruin RW; Bouwman E; Weimar W; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1385-6. PubMed ID: 3274337
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear magnetic resonance and biochemical studies to determine the synergistic detrimental effects of renal ischemia on cyclosporine nephrotoxicity in the rat.
    Chan L; Suleymanlar G; Malhotra D; Lien YH; Shapiro JI
    Transplant Proc; 1991 Feb; 23(1 Pt 1):711-3. PubMed ID: 1990660
    [No Abstract]   [Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine coverage during the risk period leads to 100% long-term graft acceptance in the rat.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1013-5. PubMed ID: 3291211
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative bone marrow injections with cyclosporine or antithymocyte globulin in rat cardiac allografts.
    Thomas WG; Sadeghi AM; Kurlansky P; Michler RE; Smith CR; Reemtsma K; Rose EA
    Transplantation; 1986 Oct; 42(4):441-2. PubMed ID: 3532457
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of cyclosporin (CSA) nephrotoxicity by imipenem/cilastatin after kidney transplantation in rats.
    Hammer C; Thies JC; Mraz W; Mihatsch M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):931. PubMed ID: 2650296
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of calcium blockade with verapamil on experimental cyclosporine nephrotoxicity.
    Orugun EO; Smart LM; Whiting PH
    Transplant Proc; 1991 Feb; 23(1 Pt 1):354-5. PubMed ID: 1990550
    [No Abstract]   [Full Text] [Related]  

  • 18. The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine.
    Erturk E; Bretan P; Pestana J; Steinmuller D; Stowe NT; Novick AC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):932-3. PubMed ID: 2705261
    [No Abstract]   [Full Text] [Related]  

  • 19. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative total-lymphoid irradiation, splenectomy, and postoperative cyclosporine in the rat cardiac heterograft model.
    Downing TP; Sadeghi AM; Bieber CP; Aziz S; Reitz BA; Shumway NE
    Transplantation; 1985 Jan; 39(1):81-3. PubMed ID: 3880968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.